natgillin/translations-raw huggingface dataset:
Reduktion af gennemsnittet af morgen og aften to- timers 1 postprandial blodglucose
Reduction of the mean of combined morning / evening two-hour postprandial 1 blood glucose
Reduktion af gennemsnitlig 1 faste blodglucose
Reduction of the mean fasting blood 1 glucose
Hyppighed af hypoglykæmi ved endpoint
Incidence of hypoglycaemia at endpoint Bodyweight gain2 1 from baseline to end of Liprolog Mix25 treatment 2
1 fra baseline til afslutning af Liprolog Mix25 behandling 2 hos patienter randomiseret til Liprolog Mix25 under den første crossover periode
in patients randomised to Liprolog Mix25 during
Undersøgrlser in vitro, der inkluderer binding til insulinreceptorer og virkning på celler i vækst, har vist, at insulin lispro virker på en måde, som minder nøje om human insulin.
In in vitro tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin.
Undersøgelser viser ligeledes, at insulin lispro og human insulin udviser samme dissociation af bindingen til
Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin.
Suspensionen skal anvendes inden for 28 dage, efter at cylinderampullen er monteret i en pen.
After insertion of the cartridge in a pen, the suspension should be used in 28 days when stored below 30°C.
5 x 3 ml Liprolog Mix25 cylinderampuller til brug i en 3 ml pen 2 x (5 x 3 ml) Liprolog Mix25 cylinderampuller til brug i en 3 ml pen.
2 x (5 x 3 ml) Liprolog Mix25 cartridges for a 3 ml pen.
Instruktioner vedrørende anvendelse og håndtering Liprolog Mix25 cylinderampuller er beregnet til at blive brugt sammen med en CE mærket pen, som anbefalet i brugsanvisningen fra fremstilleren af pennen.
Instructions for use and handling Liprolog Mix25 cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
23 a) Klargøring
a) Preparing a dose
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
Cartridges containing Liprolog Mix25 should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
Hvis dette ikke er tilfældet, gentages ovennævnte procedure, indtil indholdet er blandet.
Cartridges contain a
Cylinderampullerne indeholder en lille glaskugle for at lette opblandingen.
24 small glass bead to assist mixing.
Liprolog Mix25 cylinderampuller er udformet således, at andet insulin ikke kan blandes i ampullen.
Liprolog Mix25 cartridges are not designed to allow any other insulin to be mixed in the cartridge.
5 x 3 ml Liprolog Mix25 cylinderampuller til brug i en 3 ml pen 2 x (5 x 3 ml) Liprolog Mix25 cylinderampuller til brug i en 3 ml pen
5 x 3 ml Liprolog Mix25 cartridges for a 3 ml pen 2 x (5 x 3 ml) Liprolog Mix25 cartridges for a 3 ml pen
Liprolog Mix50 100 E/ ml injektionsvæske, suspension i cylinderampul.
Liprolog Mix50 100 U/ ml suspension for injection in cartridge
Liprolog Mix50 er indiceret til behandling af patienter med diabetes mellitus, der kræver insulin til opretholdelse af normal glukose homøostase.
Liprolog Mix50 is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Virkningsvarigheden af insulin lispro protaminsuspension (BASAL) - delen af Liprolog Mix50 svarer til virkningsvarigheden af basal insulin (isophan).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix50 is similar to that of a basal insulin (NPH).
26 Hypoglykæmi.
26 Hypoglycaemia.
Insulinbehovet kan være nedsat under samtidig behandling med lægemidler med hypoglykæmisk aktivitet, f. eks. orale antidiabetika, salicylater (f. eks. acetylsalicylsyre), sulfapræparater, visse antidepressiva (monoaminooxidasehæmmere), visse angiotensin konverteringsenzym (ACE) - hæmmere (captopril, enalapril), angiotensin II- receptorblokkere, beta- blokkere, octreotid eller alkohol.
Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants, (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
Lægen bør konsulteres, når der tages anden medicin samtidig med Liprolog Mix50.
The physician should be consulted when using other medications in addition to Liprolog Mix50.
Data fra et stort antal eksponerede graviditeter indikerer ingen bivirkninger af insulin lispro på graviditeten eller på fosterets/ spædbarnets helbred.
27 Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn.
27 Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
Hvis patienten er bevidstløs, bør glukagon gives intramuskulært eller subkutant.
28 If the patient is comatose, glucagon should be administered intramuscularly or subcutaneously.
28 Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.
Virkningsprofilen af Liprolog BASAL svarer til virkningsprofilen af basal insulin (isophan) over en tidsperiode på ca.
Liprolog Basal has an activity profile that is very similar to that of a basal insulin (NPH) over a period of approximately 15 hours.
Farmakodynamikken for Liprolog Mix50 og Liprolog BASAL illustreres nedenfor.
In the figure below the pharmacodynamics of Liprolog Mix50 and Liprolog Basal are illustrated.
Humalog Mix50 NPL
Liprolog Liprolog Basall
Det glukodynamiske respons på insulin lispro påvirkes ikke af nedsat nyre - eller leverfunktion.
29 The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment.
29 5. 2 Farmakokinetiske egenskaber
5.2 Pharmacokinetic properties
Suspensionen skal anvendes inden for 28 dage, efter at cylinderampullen er monteret i en pen.
30 After insertion of the cartridge in a pen, the suspension should be used in 28 days when stored below 30°C.
Instruktioner vedrørende anvendelse og håndtering Liprolog Mix50 cylinderampuller er beregnet til at blive brugt sammen med en CE mærket pen, som anbefalet i brugsanvisningen fra fremstilleren af pennen.
Instructions for use and handling Liprolog Mix50 cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
Cartridges containing Liprolog Mix50 should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
Liprolog Mix50 cylinderampuller er udformet således, at andet insulin ikke kan blandes i ampullen.
Liprolog Mix50 cartridges are not designed to allow any other insulin to be mixed in the cartridge.
5 x 3 ml Liprolog Mix50 cylinderampuller til brug i en 3 ml pen 2 x (5 x 3 ml) Liprolog Mix50 cylinderampuller til brug i en 3 ml pen
5 x 3 ml Liprolog Mix50 cartridges for a 3 ml pen 2 x (5 x 3 ml) Liprolog Mix50 cartridges for a 3 ml pen
Liprolog BASAL 100 E/ ml injektionsvæske, suspension i cylinderampul.
Liprolog Basal 100 U/ ml suspension for injection in cartridge
Liprolog BASAL er en insulin lispro protaminsuspension.
Liprolog Basal consists of insulin lispro protamine suspension.
Liprolog BASAL er en hvid, steril suspension.
Liprolog Basal is a white, sterile suspension.
Liprolog BASAL er indiceret til behandling af patienter med diabetes mellitus, der kræver insulin til opretholdelse af normal glukose homøostase.
Liprolog Basal is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Liprolog BASAL kan anvendes alene, i kombination med orale antidiabetika eller blandet med insulin lispro opløsning.
Liprolog Basal may be used alone, in combination with oral agents, or mixed with insulin lispro solution.
Ved intensiv insulinterapi kan Liprolog BASAL bruges som basisinsulin (injiceres om aftenen og/ eller om morgenen), og hurtigtvirkende insulin gives til måltiderne.
In intensive insulin therapy Liprolog Basal may be used as basal insulin (evening and/ or morning injection) with fast-acting insulin given at meals.
Liprolog BASAL bør kun gives som subkutan injektion.
Liprolog Basal should only be given by subcutaneous injection.
Liprolog BASAL bør under ingen omstændigheder gives intravenøst.
Under no circumstance should Liprolog Basal be given intravenously.
6. 6).
Subcutaneous administration should be in the upper arms, thighs, buttocks, or abdomen (see section 6.6).
Ved subkutan injektion af Liprolog BASAL skal man være påpasselig med ikke at injicere direkte i et blodkar.
When administered subcutaneously care should be taken when injecting Liprolog Basal to ensure that a blood vessel has not been entered.
Som med alle insulinpræparater afhænger virkningsvarigheden af Liprolog BASAL af dosis, indstikssted, blodtilførsel, temperatur og fysisk aktivitet.
As with all insulin preparations, the duration of action of Liprolog Basal is dependent on dose, site of injection, blood supply, temperature, and physical activity.
33 4. 4 Særlige advarsler og forsigtighedsregler vedrørende brugen
33 4.4 Special warnings and precautions for use
Liprolog BASAL bør under ingen omstændigheder gives intravenøst.
Under no circumstances should Liprolog Basal be given intravenously.
Det er ikke undersøgt, hvorvidt Liprolog BASAL kan blandes med andet insulin.
Mixing Liprolog Basal with insulins other than Liprolog has not been studied.
Lægen bør konsulteres, når der tages anden medicin samtidig med Liprolog BASAL.
The physician should be consulted when using other medications in addition to Liprolog Basal.
Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
34 It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
Lokale allergiske reaktioner er almindeligt forekommende (≥1/ 100 til < 1/ 10).
Local allergy in patients is common (1/ 100 to < 1/ 10).
Systemisk allergi, som er sjælden (≥1/ 10. 000 til < 1/ 1. 000), men potentielt mere alvorlig, er en generaliseret overfølsomhed over for insulin.
Systemic allergy, which is rare (1/ 10,000 to < 1/ 1,000) but potentially more serious, is a generalised allergy to insulin.
Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
35 Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.
6 timer efter administrationen.
Liprolog Basal has a prolonged absorption profile, achieving a maximum insulin concentration approximately 6 hours after dosing.
Saltsyre og natriumhydroxid kan være tilsat for at justere pH til 7, 0- 7, 8.
Protamine sulphate m-cresol [1.76 mg/ ml] 36 Phenol [0.80 mg/ ml] Glycerol Dibasic sodium phosphate.7H2O Zinc oxide Water for injections Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0 – 7.8.
Det er ikke undersøgt, hvorvidt Liprolog BASAL kan blandes med andet insulin end Liprolog.
Mixing Liprolog Basal with insulins other than Liprolog has not been studied.
Suspensionen skal anvendes inden for 21 dage, efter at cylinderampullen er monteret i en pen.
After insertion of the cartridge in a pen, the suspension should be used in 21 days when stored below 30°C.
5 x 3 ml Liprolog BASAL cylinderampuller til brug i en 3 ml pen 2 x (5 x 3 ml) Liprolog BASAL cylinderampuller til brug i en 3 ml pen
5 x 3 ml Liprolog Basal cartridges for a 3 ml pen 2 x (5 x 3 ml) Liprolog Basal cartridges for a 3 ml pen
Instruktioner vedrørende anvendelse og håndtering Liprolog BASAL cylinderampuller er beregnet til at blive brugt sammen med en CE mærket pen, som anbefalet i brugsanvisningen fra fremstilleren af pennen.
Instructions for use and handling Liprolog Basal cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Insulinet skal fremtræde ensartet uklart eller mælkehvidt.
Cartridges containing Liprolog Basal should be rotated in the palms of the hands ten times and inverted 180° ten times immediately before use to resuspend the insulin until it appears uniformly cloudy or milky.
Liprolog BASAL cylinderampuller er udformet således, at andet insulin ikke kan blandes i ampullen.
Liprolog Basal cartridges are not designed to allow any other insulin to be mixed in the cartridge.
37 b) Injektion
37 The following is a general description.
DATO FOR ÆNDRING AF TEKSTEN 1.
DATE OF REVISION OF THE TEXT
Liprolog Pen 100 E/ ml, injektionsvæske, opløsning
Liprolog Pen 100 U/ ml, solution for injection
Liprolog Pen er en steril, klar, farveløs, vandig opløsning.
Liprolog Pen is a sterile, clear, colourless, aqueous solution.
Liprolog Pen er også indiceret til initial stabilisering af diabetes mellitus.
Liprolog Pen is also indicated for the initial stabilisation of diabetes mellitus.
Ved subkutan injektion af Liprolog Pen skal man være påpasselig med ikke at injicere direkte i et blodkar.
When administered subcutaneously care should be taken when injecting Liprolog Pen to ensure that a blood vessel has not been entered.
Liprolog Pen har en hurtigt indsættende virkning og en kortere virkningsvarighed (2- 5 timer), ved subkutan injektion, end opløselig insulin.
Liprolog Pen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.
Som med alle insulinpræparater afhænger virkningsvarigheden af Liprolog Pen af dosis, indstikssted, blodtilførsel, temperatur og fysisk aktivitet.
As with all insulin preparations, the duration of action of Liprolog Pen is dependent on dose, site of injection, blood supply, temperature, and physical activity.
I samråd med en læge må Liprolog bruges sammen med længerevirkende human insulin eller orale sulfonylurinstoffer.
39 Liprolog can be used in conjunction with a longer-acting human insulin or oral sulphonylurea agents, on the advice of a physician.
Brug af Liprolog i en insulin infusionspumpe Kun visse CE- mærkede insulininfusionspumper kan anvendes til infusion af insulin lispro.
Only certain CE-marked insulin infusion pumps may be used to infuse insulin lispro.
En fejl ved pumpen eller
If repeated or severe low blood glucose levels occur, notify your health care professional and consider the need to reduce or stop your insulin infusion.
39 tilstopning af infusionssættet kan resultere i en hurtig stigning af blodglukosekoncentrationen.
A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels.
Insulinbehovet kan øges ved sygdom eller følelsesmæssige belastninger.
40 Insulin requirements may be increased during illness or emotional disturbances.
40 4. 5 Interaktion med andre lægemidler og andre former for interaktion
4.5 Interaction with other medicinal products and other forms of interaction
Insulinbehovet kan være nedsat under samtidig behandling med lægemidler med hypoglykæmisk aktivitet, f. eks. orale antidiabetika, salicylater (f. eks. acetylsalicylsyre), sulfapræparater, visse antidepressiva (monoaminooxidasehæmmere), visse angiotensin konverteringsenzym (ACE) - hæmmere (captopril, enalapril), angiotensin II- receptorblokkere, beta- blokkere, octreotid eller alkohol.
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol.
Lægen bør konsulteres, når der tages anden medicin samtidig med Liprolog Pen.
The physician should be consulted when using other medications in addition to Liprolog Pen.
Lokale allergiske reaktioner er almindeligt forekommende (≥ 1/ 100 til < 1/ 10).
41 Local allergy in patients is common (1/ 100 to < 1/ 10).
41 4. 9 Overdosering
4.9 Overdose
ATCkode:
Fast-acting human insulin analogue, ATC code:
Som med alle insulinpræparater kan virkningsvarigheden af insulin lispro variere både fra person til person og på forskellige tidspunkter hos samme person og afhænger af dosis, indstikssted, blodtilførsel, temperatur og fysisk aktivitet.
42 As with all insulin preparations, the time course of insulin lispro action may vary in different individuals or at different times in the same individual and is dependent on dose, site of injection, blood supply, temperature and physical activity.
42 Insulin lispro Humulin Regular Hypoglykæmisk aktivitet
Insulin lispro Humulin R Hypoglycemic Activity
Farmakokinetikken af insulin lispro afspejler hurtig absorption og opnåelse af maksimal plasmakoncentration 30- 70 minutter efter subkutan injektion.
When considering the clinical
5. 1).
43 relevance of these kinetics, it is more appropriate to examine the glucose utilisation curves (as discussed in 5.1).
43 hurtigere absorption og elimination af insulin lispro sammenlignet med opløselig human insulin opretholdes hos patienter med nedsat leverfunktion.
Insulin lispro maintains more rapid absorption and elimination when compared to soluble human insulin in patients with hepatic impairment.
Liprolog Pen bør ikke blandes med insulinpræparater fremstillet af andre producenter eller med animalske insulinpræparater.
Liprolog preparations should not be mixed with insulins produced by other manufacturers or with animal insulin preparations.
5 x 3 ml penne 2 x (5 x 3 ml) penne.
44 5 x 3 ml Pens 2 x (5 x 3 ml) Pens
44 Instruktioner vedrørende anvendelse og håndtering a) Klargøring
Instructions for use and handling a) Preparing a dose
Kontroller Liprolog Pen- opløsningen.
Inspect the Liprolog Pen solution.
Brug ikke Liprolog Pen, hvis insulinet virker uklart, tyktflydende, er let farvet, eller hvis der ses småpartikler i væsken.
Do not use Liprolog Pen if it appears cloudy, thickened, or slightly coloured or if solid particles are visible.
5 x 3 ml penne 2 x (5 x 3 ml) penne
5 x 3 ml Pens 2 x (5 x 3 ml) Pens
Liprolog Mix25 100 E/ ml Pen injektionsvæske, suspension
Liprolog Mix25 100 U/ ml Pen, suspension for injection
Virkningsvarigheden af insulin lispro protaminsuspension (BASAL) - delen af Liprolog Mix25 svarer til virkningsvarigheden af basal insulin (isophan).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix25 is similar to that of a basal insulin (NPH).
47 Hypoglykæmi.
47 Hypoglycaemia.
Data fra et stort antal eksponerede graviditeter indikerer ingen bivirkninger af insulin lispro på graviditeten eller på fosterets/ spædbarnets helbred.
48 Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn.
48 Det er vigtigt at opretholde god kontrol med insulinbehandlede patienter (insulinkrævende eller svangerskabsbetinget diabetes) under graviditeten.
It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
Hvis patienten er bevidstløs, bør glukagon gives intramuskulært eller subkutant.
49 If the patient is comatose, glucagon should be administered intramuscularly or subcutaneously.
49 Vedvarende indtag af kulhydrater samt observation kan være nødvendigt, idet hypoglykæmi kan gentage sig efter en tilsyneladende klinisk bedring.
Sustained carbohydrate intake and observation may be necessary because hypoglycaemia may recur after apparent clinical recovery.
Liprolog Mix25 er en færdigblandet suspension af insulin lispro (hurtigt virkende human insulin- analog) og insulin lispro protaminsuspension (middelhurtigt virkende human insulin- analog).
Liprolog Mix25 is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue).
Hypoglykæmis k aktivitet
Hypoglycaemic activity Liprolog Mix25 Liprolog Basal
De ovenfor anførte kurver illustrerer den relative mængde glukose, som over tid er nødvendig for at opretholde blodglukose- koncentrationer nær fasteniveau, og viser samtidig den tidsrelaterede effekt af disse insuliner på glukosemetabolismen.
50 The above representation reflects the relative amount of glucose over time required to maintain the subject's whole blood glucose concentrations near fasting levels and is an indicator of the effect of these insulins on glucose metabolism over time.
50 Det er vist, at insulin lispro på molekylært niveau er lige så potent som human insulin, men dets effekt er hurtigere og af kortere varighed.
Insulin lispro has been shown to be equipotent to human insulin on a molar basis but its effect is more rapid and of a shorter duration.
I dyrestudier medførte insulin lispro hverken nedsat fertilitet, embryotoksicitet eller teratogenicitet.
51 Insulin lispro did not induce fertility impairment, embryotoxicity or teratogenicity in animal studies.
Suspensionen opbevares i Type 1 flintglas cylinderampuller, forseglede med halobutyl gummimem - braner og stempelhoveder og sikrede med aluminiumforseglinger.
The suspension is contained in type I flint glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals.
5 x 3 ml Liprolog Mix25 100 E/ ml Pen 2 x (5 x 3 ml) Liprolog Mix25 100 E/ ml Pen
2 x (5 x 3 ml) Liprolog Mix25 100 U/ ml Pens.
Kontroller Liprolog Mix25 Pen.
Inspect the Liprolog Mix25 100 U/ ml Pen.
Hvis dette ikke er tilfældet, gentages ovennævnte procedure, indtil indholdet er blandet..
If not, repeat the above procedure until contents are mixed.
Cylinderampullerne indeholder en lille glaskugle for at lette opblandingen.
Do not
Ryst ikke kraftigt, da dette kan forårsage, at indholdet skummer, hvilket kan påvirke den korrekte afmåling af dosis.
52 shake vigorously as this may cause frothing which may interfere with the correct measurement of the dose.
52 Cylinderampullerne bør kontrolleres jævnligt og bør ikke bruges, hvis de indeholder klumper, eller hvis faste hvide partikler, der ligner rimfrost, har sat sig fast på bunden eller på siden af ampullen.
The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving a frosted appearance.
53 7.
53 7.
EU/ 1/ 01/ 195/ 006 EU/ 1/ 01/ 195/ 024
EU/ 1/ 01/ 195/ 006 EU/ 1/ 01/ 195/ 014
5 x 3 ml Liprolog Mix25 100 E/ ml Penne 2 x (5 x 3 ml) Liprolog Mix25 100 E/ ml Penne
5 x 3 ml Liprolog Mix25 100 U/ ml Pens 2 x (5 x 3 ml) Liprolog Mix25 100 U/ ml Pens
Liprolog Mix50 100 E/ ml Pen injektionsvæske, suspension
Liprolog Mix50 100 U/ ml Pen, suspension for injection
Virkningsvarigheden af insulin lispro protaminsuspension (BASAL) - delen af Liprolog Mix50 svarer til virkningsvarigheden af basal insulin (isophan).
The duration of action of the insulin lispro protamine suspension (Basal) component of Liprolog Mix50 is similar to that of a basal insulin NPH.
Overfølsomhed over for insulin lispro eller over for et eller flere af hjælpestofferne.
55 Hypersensitivity to insulin lispro or to any of the excipients.
55 Hypoglykæmi.
Hypoglycaemia.
Data fra et stort antal eksponerede graviditeter indikerer ingen bivirkninger af insulin lispro på graviditeten eller på fosterets/ spædbarnets helbred.
56 Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn.